Jonathan I. Silverberg
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
2020/01/30 by E.L. Simpson, Eric L. Simpson, J.‐P. Lacour +43 · 29 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Allergic Rhinitis and Sensitization
- Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*
2020/10/01 by Jonathan I. Silverberg, J.I. Silverberg, D. Toth +19 · 29 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Allergic Rhinitis and Sensitization
- Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
2019/01/01 by Emma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar +17 · 4 citations
- Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
2022/09/09 by Eric L. Simpson, Joseph F. Merola, Jonathan I. Silverberg +13 · 27 citations
Medicine · #Dermatology and Skin Diseases #Asthma and respiratory diseases #Allergic Rhinitis and Sensitization
- Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
2023/03/30 by Andrew Blauvelt, Jacob P Thyssen, Jacob P. Thyssen +19 · 26 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Asthma and respiratory diseases
- Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults
2016/03/31 by Derek Y. Hsu, Joaquin C. Brieva, Joaquin Brieva +2 · 2 citations
Medicine · #Drug-Induced Adverse Reactions #Urticaria and Related Conditions #Autoimmune Bullous Skin Diseases